Amber’s recent experience includes serving on Weil teams representing biotechnology company Illumina in an infringement dispute with Chinese conglomerate BGI regarding DNA sequencers.

Amber received her J.D. from Columbia Law School, where she was a Harlan Fiske Stone Scholar. She holds an M.S.E. in bioengineering from the University of Pennsylvania, and a B.S.E. in biomedical engineering from Duke University, where she was on Dean’s List and Dean’s List with Distinction.

Amber is fluent in Mandarin Chinese.